Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Blood|June 11, 2017
The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practiceFrank C Kuo, Brenton G Mar, R Coleman Lindsley, et al.
The American Journal of Surgical Pathology|January 15, 2014
Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaDaniel F Boyer, Neal I Lindeman, Nancy Lee Harris, et al.
Clinical Chemistry and Laboratory Medicine|October 20, 2012
Refrigeration is not necessary for measurement of uric acid in patients treated with rasburicaseNeal I Lindeman, Stacy E F Melanson, Anne McDonnell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2015
Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancerDorothy Romanus, Stephanie Cardarella, David Cutler, et al.
American Journal of Clinical Pathology|August 20, 2013
An improved algorithm for activated protein C resistance and factor V Leiden screeningAdrianna Z Herskovits, Elizabeth A Morgan, Susan J Lemire, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2015
Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genesGabriel K Griffin, Lynette M Sholl, Neal I Lindeman, et al.
Experimental Hematology & Oncology|October 13, 2015
Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencingDiana Mandelker, Paola Dal Cin, Heather A Jacene, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemiaChristina K Tripsas, Christopher J Patterson, Sacha N Uljon, et al.
Gynecologic Oncology|June 26, 2018
Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitorAllison A Gockley, David L Kolin, Christopher S Awtrey, et al.
Pageof 14